Literature DB >> 4040361

Microbiology of chronic otitis media with effusion among Australian Aboriginal children: role of Chlamydia trachomatis.

V M Dawson, R J Coelen, S Murphy, D Graham, H Dyer, J Sunderman.   

Abstract

Serum, eye secretions, post-nasal swabs, external ear swabs and middle ear effusions (MEE) were collected from 131 Australian Aboriginal children with chronic otitis media with effusion (COME). The children were all resident in a trachoma endemic region. Chlamydia trachomatis was recovered from the MEE of 2 children. Probable bacterial pathogens were isolated from 34 (12.7%) ears. The remainder were sterile (52.4%) or contained normal skin flora (34.9%). Serum and secretions were examined by the microimmunofluorescent technique for the presence, titre and serotype of anti-chlamydial antibody. Antibody, predominantly of the C serotype, was found in a high percentage of sera (80%) and secretions (approximately 50%). This serotype is associated with ocular trachoma. It is concluded that C. trachomatis is associated with COME among some Aboriginal children in this trachoma endemic area.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4040361     DOI: 10.1038/icb.1985.12

Source DB:  PubMed          Journal:  Aust J Exp Biol Med Sci        ISSN: 0004-945X


  3 in total

1.  The Role of Chlamydia in Upper Respiratory Tract Infections.

Authors: 
Journal:  Curr Infect Dis Rep       Date:  2000-04       Impact factor: 3.725

2.  The unsolved problem of otitis media in indigenous populations: a systematic review of upper respiratory and middle ear microbiology in indigenous children with otitis media.

Authors:  Andrea Coleman; Amanda Wood; Seweryn Bialasiewicz; Robert S Ware; Robyn L Marsh; Anders Cervin
Journal:  Microbiome       Date:  2018-11-05       Impact factor: 14.650

Review 3.  Predominant Bacteria Detected from the Middle Ear Fluid of Children Experiencing Otitis Media: A Systematic Review.

Authors:  Chinh C Ngo; Helen M Massa; Ruth B Thornton; Allan W Cripps
Journal:  PLoS One       Date:  2016-03-08       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.